Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 215058
Company: INGENUS PHARMS LLC
Company: INGENUS PHARMS LLC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
LIFITEGRAST | LIFITEGRAST | 5% | SOLUTION;OPHTHALMIC | None (Tentative Approval) | None | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
02/15/2023 | ORIG-1 | Tentative Approval | STANDARD |
Letter (PDF)
|
Label is not available on this site. |
https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/215058Orig1s000TAltr.pdf |